When clinical trials were conducted to determine the immunogenicity -- the ability to elicit an immune response -- for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
from Latest Science News -- ScienceDaily https://ift.tt/3tTl0L5
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment